Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horsley Bridge Partners is a private equity fund-of-funds manager focused primarily on technology venture capital and growth buyout partnerships rather than a drug-development or healthcare operating company. Founded in 1983, the firm invests in carefully selected private equity managers and operates from San Francisco with an international presence in London and Beijing. The organization appears to be active and independent, and is commonly referred to as HBP. Because Horsley Bridge is an investment firm rather than a biotech, pharma, or healthcare developer, it does not have a therapeutic pipeline, clinical-stage assets, or disease-specific programs of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horsley Bridge Partners.